Literature DB >> 17151367

The myeloproliferative disorders.

Peter J Campbell1, Anthony R Green.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17151367     DOI： 10.1056/NEJMra063728

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  161 in total

Review 1.  A potential role of ruxolitinib in leukemia.

Authors:  Kiran Naqvi; Srdan Verstovsek; Hagop Kantarjian; Farhad Ravandi
Journal:  Expert Opin Investig Drugs       Date:  2011-06-03       Impact factor: 6.206

Review 2.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

Review 3.  Immune regulation by phospholipase C-β isoforms.

Authors:  Wenbin Xiao; Yuko Kawakami; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

4.  Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms.

Authors:  Thomas Ernst; Andrew Chase; Katerina Zoi; Katherine Waghorn; Claire Hidalgo-Curtis; Joannah Score; Amy Jones; Francis Grand; Andreas Reiter; Andreas Hochhaus; Nicholas C P Cross
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

5.  Activation of JAK2-V617F by components of heterodimeric cytokine receptors.

Authors:  Anuradha Pradhan; Que T Lambert; Lori N Griner; Gary W Reuther
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

6.  IDH1 R132H mutation is a rare event in myeloproliferative neoplasms as determined by a mutation specific antibody.

Authors:  Mindaugas Andrulis; David Capper; Jochen Meyer; Roland Penzel; Christian Hartmann; Hanswalter Zentgraf; Andreas von Deimling
Journal:  Haematologica       Date:  2010-06-09       Impact factor: 9.941

7.  Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera.

Authors:  Mutlu Karkucak; Tahsin Yakut; Vildan Ozkocaman; Fahir Ozkalemkas; Ridvan Ali; Murat Bayram; Orhan Gorukmez; Gokhan Ocakoglu
Journal:  Mol Biol Rep       Date:  2012-06-22       Impact factor: 2.316

8.  Characterization of a highly effective protein substrate for analysis of JAK2(V617F) Activity.

Authors:  Zhe Li; Shu Xing; Shaofeng Wang; Wanting Tina Ho; Zhizhuang Joe Zhao
Journal:  Exp Hematol       Date:  2007-08-30       Impact factor: 3.084

9.  Stable-Isotope Dilution HPLC-Electrospray Ionization Tandem Mass Spectrometry Method for Quantifying Hydroxyurea in Dried Blood Samples.

Authors:  Anu Marahatta; Vandana Megaraj; Patrick T McGann; Russell E Ware; Kenneth D R Setchell
Journal:  Clin Chem       Date:  2016-09-30       Impact factor: 8.327

Review 10.  Prognosis of Primary Myelofibrosis in the Genomic Era.

Authors:  Prithviraj Bose; Srdan Verstovsek
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.